CLDN1 is a therapeutic target in primary sclerosing cholangitis
Nov. 22, 2022
Primary sclerosing cholangitis (PSC) is a disease affecting the bile ducts that can lead to end-stage liver disease and cholangiocarcinoma. Patients with this disease lack therapeutic treatment other than liver transplantation.